Concurrent chemoradiotherapy and brachytherapy boost for base of tongue cancer treatment outcomes.
W.F. Mourad(Mount Sinai Beth Israel), L.B. Harrison(Moffitt Cancer Center), B. Culliney(Mount Sinai Beth Israel), A. Jacobson(Action for ME), Kenneth S. Hu(Mount Sinai Beth Israel), Mark L. Urken(Icahn School of Medicine at Mount Sinai), Stimson P. Schantz(The University of Texas MD Anderson Cancer Center), Peter Costantino, T.C.K. Tran(Erasmus MC), M. Perksy
Cited by 0
Related Papers
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k
Body composition and outcome in patients undergoing resection of colorectal liver metastases19
|British journal of surgery|2012|464
Cardiovascular Events in Patients With Fabry Disease
|Journal of the American College of Cardiology|2011|171
Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
|British Journal of Cancer|2006|127